Shares Outstanding for Vertex Pharmaceuticals (VRTX)
According to Vertex Pharmaceuticals's latest reported financial statements, the company's latest reported diluted shares outstanding is 256.10M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingShares OutstandingSwitch metric
Latest period
256.10M
YoY change
+0.0%
5Y CAGR
-0.4%
Peak year (2020)
263.40M
Latest annual
258.00M
Shares Outstanding history chart for Vertex Pharmaceuticals (VRTX) from 1990 to 2025
Shares Outstanding history table for Vertex Pharmaceuticals (VRTX) from 1990 to 2025
| Fiscal year | Period ended | Reported | Shares Outstanding | YoY |
|---|---|---|---|---|
| 2025 | 258.00M | +0.0% | ||
| 2024 | 257.90M | -1.0% | ||
| 2023 | 260.50M | +0.5% | ||
| 2022 | 259.10M | -0.3% | ||
| 2021 | 259.90M | -1.3% | ||
| 2020 | 263.40M | +1.0% | ||
| 2019 | 260.67M | +0.6% | ||
| 2018 | 259.19M | +2.4% | ||
| 2017 | 253.22M | +3.5% | ||
| 2016 | 244.69M | +1.4% | ||
| 2015 | 241.31M | +2.6% | ||
| 2014 | 235.31M | +4.6% | ||
| 2013 | 224.91M | +6.1% | ||
| 2012 | 211.95M | +1.5% | ||
| 2011 | 208.81M | +4.2% | ||
| 2010 | 200.40M | +15.7% | ||
| 2009 | 173.26M | +23.3% | ||
| 2008 | 140.56M | +9.0% | ||
| 2007 | 128.99M | +13.9% | ||
| 2006 | 113.22M | +26.9% | ||
| 2005 | 89.24M | +13.6% | ||
| 2004 | 78.57M | +2.0% | ||
| 2003 | 77.00M | +1.7% | ||
| 2002 | 75.75M | +1.7% | ||
| 2001 | 74.46M | +10.0% | ||
| 2000 | 67.68M | +32.6% | ||
| 1999 | 51.04M | +0.9% | ||
| 1998 | 50.60M | +4.3% | ||
| 1997 | 48.53M | +29.8% | ||
| 1996 | 37.38M | +9.5% | ||
| 1995 | 34.13M | +8.6% | ||
| 1994 | 31.43M | +25.7% | ||
| 1993 | 25.00M | +2.9% | ||
| 1992 | 24.29M | +66.2% | ||
| 1991 | 14.62M | -25.7% | ||
| 1990 | 19.68M | — |
Shares Outstanding values are taken from Vertex Pharmaceuticals's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Vertex Pharmaceuticals (VRTX) diluted shares outstanding is 258.00M – edged up 0.0% year-over-year.
Across 2020–2025 (5 years), Vertex Pharmaceuticals diluted shares outstanding produced a CAGR of -0.4% – with a net decline across the window.
Between 2020 and 2025, Vertex Pharmaceuticals diluted shares outstanding edged down 2.0%, falling from 263.40M to 258.00M.
The highest annual diluted shares outstanding of 263.40M was reported in 2020. The lowest in the available history was 14.62M in 1991.
Within Healthcare, Vertex Pharmaceuticals (VRTX) ranks 9th among 8 peers we track. The peer median for diluted shares outstanding is 1.34B.
Vertex Pharmaceuticals Shares Outstanding by Year
Vertex Pharmaceuticals Shares Outstanding 2025: 258.00M
Vertex Pharmaceuticals diluted shares outstanding in 2025 was 258.00M, edged up 0.0% from 2024.
Vertex Pharmaceuticals Shares Outstanding 2024: 257.90M
Vertex Pharmaceuticals diluted shares outstanding in 2024 was 257.90M, edged down 1.0% below 2023.
Vertex Pharmaceuticals Shares Outstanding 2023: 260.50M
Vertex Pharmaceuticals diluted shares outstanding in 2023 was 260.50M, edged up 0.5% from 2022.
Vertex Pharmaceuticals Shares Outstanding 2022: 259.10M
Vertex Pharmaceuticals diluted shares outstanding in 2022 was 259.10M, edged down 0.3% below 2021.
Vertex Pharmaceuticals Shares Outstanding 2021: 259.90M
Vertex Pharmaceuticals diluted shares outstanding in 2021 was 259.90M.
See more financial history for Vertex Pharmaceuticals (VRTX).
Sector peers — Shares Outstanding
Companies in the same sector as Vertex Pharmaceuticals, ranked by their latest diluted shares outstanding.
| Company | Shares Outstanding | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | 4.45B | Healthcare |
| Merck & Co., Inc. (MRK) | 2.51B | Healthcare |
| Johnson & Johnson (JNJ) | 2.43B | Healthcare |
| AbbVie Inc. (ABBV) | 1.77B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | 910.00M | Healthcare |
| Eli Lilly and Company (LLY) | 898.00M | Healthcare |
| AstraZeneca PLC (AZN) | 781.00M | Healthcare |
| Amgen Inc. (AMGN) | 542.00M | Healthcare |
Frequently asked questions
What is Vertex Pharmaceuticals's diluted shares outstanding?
- Latest reported diluted shares outstanding for Vertex Pharmaceuticals (VRTX) is 256.10M (period ending December 31, 2025).
How has Vertex Pharmaceuticals diluted shares outstanding changed year-over-year?
- Vertex Pharmaceuticals (VRTX) diluted shares outstanding changed +0.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Vertex Pharmaceuticals diluted shares outstanding?
- Vertex Pharmaceuticals (VRTX) diluted shares outstanding compound annual growth rate is -0.4% over the most recent 5 years available.
When did Vertex Pharmaceuticals diluted shares outstanding hit its highest annual value?
- Vertex Pharmaceuticals diluted shares outstanding reached its highest annual value of 263.40M in 2020.
What was Vertex Pharmaceuticals diluted shares outstanding in 2024?
- Vertex Pharmaceuticals (VRTX) diluted shares outstanding in 2024 was 257.90M.
What was Vertex Pharmaceuticals diluted shares outstanding in 2025?
- Vertex Pharmaceuticals (VRTX) diluted shares outstanding in 2025 was 258.00M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
VRTX Overview
Company profile, financial tools, and key metrics
VRTX Revenue Counter
Earns $381.74 every second. See per minute, hour, and day.
VRTX Earnings Counter
Earns $125.36 per second net profit. See per minute, hour, and day.
VRTX Economic Scale
Exceeds Somalia, Fed. Rep.'s GDP. Compare with world economies.
VRTX What If Invested
What if you had invested $1,000? See historical returns from any date.
VRTX How It Makes Money
Discover visual breakdown of $12.04B in revenue — where it comes from and where it goes.
VRTX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
VRTX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
VRTX Daily Price Character
Explosive · 48.3% historical win rate (green days). Streaks & record days.
VRTX Buybacks
1.75% TTM buyback yield. Shareholder yield & SBC comparison.
VRTX Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.